Table 2.

ASCT Outcomes and Toxicities (n=29)

Event	Median (range)
Days to neutrophil engraftment	9 (8,12)
Days to platelet engraftment	11 (8,40)
Hospital stay in days	23 (18,56)
Infection	N (%)
Bacterial	9 (31)
Fungal	1 (3)
Viral	1 (3)
Engraftment syndrome	6 (21)
Veno-occlusive disease (VOD)	0 (0)
Cardiac toxicity	0 (0)
Hemorrhagic cystitis	0 (0)
DAH / IPS	0 (0)
CNS toxicity	2 (7)
100-day NRM	0 (0)
1-year NRM	1 (3)
Therapy-related MDS or AML	0 (0)

Abbreviations: ANC= Absolute neutrophil count; CNS=Central nervous system; MDS = myelodysplastic syndrome; AML = acute myeloid leukemia; NRM = non-relapse mortality

Neutrophil engraftment was defined by ANC > 500 on two consecutive days

Platelet engraftment was defined by platelets > 20,000 / ul on two consecutive days unsupported by transfusions